Caspase function in programmed cell death

Cell Death and Differentiation - Tập 14 Số 1 - Trang 32-43 - 2007
Sharad Kumar1
1Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, SA, Australia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768–774.

Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA et al. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97–100.

Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641–652.

Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653–660.

Kumar S, Tomooka Y, Noda M (1992) Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun 185: 1155–1161.

Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA (1994) Induction of apoptosis by mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 8: 1613–1626.

Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P (2002) Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 9: 358–361.

Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384: 201–232.

Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22: 8543–8567.

Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817–829.

Shaham S (1998) Identification of multiple Caenorhabditis elegans caspases and their potential roles in proteolytic cascades. J Biol Chem 273: 35109–35117.

Lettre G, Hengartner MO (2006) Developmental apoptosis in C. elegans: a complex CEDnario. Nat Rev Mol Cell Biol 7: 97–108.

Yan N, Chai J, Lee ES, Gu L, Liu Q, He J et al. (2005) Structure of the CED-4–CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 437: 831–837.

Song Z, McCall K, Steller H (1997) DCP-1, a Drosophila cell death protease essential for development. Science 275: 536–540.

Chen P, Rodriguez A, Erskine R, Thach T, Abrams JM (1998) Dredd, a novel effector of the apoptosis activators reaper, grim and hid in Drosophila. Dev Biol 201: 202–216.

Fraser AG, Evan GI (1997) Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE. EMBO J 16: 2805–2813.

Dorstyn L, Colussi PA, Quinn LM, Richardson H, Kumar S (1999) DRONC, a novel ecdysone-inducible Drosophila caspase. Proc Natl Acad Sci USA 96: 4307–4312.

Dorstyn L, Read SH, Quinn LM, Richardson H, Kumar S (1999) DECAY, a novel Drosophila caspase related to mammalian caspase-3 and caspase-7. J Biol Chem 274: 30778–30783.

Harvey NL, Daish T, Mills K, Dorstyn L, Quinn LM, Read SH et al. (2001) Characterization of the Drosophila caspase, DAMM. J Biol Chem 276: 25342–25350.

Doumanis J, Quinn L, Richardson H, Kumar S (2001) STRICA, a novel Drosophila caspase with an unusual serine/threonine-rich prodomain, interacts with DIAP1 and DIAP2. Cell Death Diff 8: 387–394.

Kumar S, Doumanis J (2000) The fly caspases. Cell Death Diff 7: 1039–1044.

Leulier F, Rodriguez A, Khush RS, Abrams JM, Lemaitre B (2000) The Drosophila caspase Dredd is required to resist gram-negative bacterial infection. EMBO Rep 1: 353–358.

Hu S, Yang X (2000) dFADD, a novel death domain-containing adapter protein for the Drosophila caspase DREDD. J Biol Chem 275: 30761–30764.

Zhou R, Silverman N, Hong M, Liao DS, Chung Y, Chen ZJ et al. (2005) The role of ubiquitination in Drosophila innate immunity. J Biol Chem 280: 34048–34055.

Huh JR, Vernooy SY, Yu H, Yan N, Shi Y, Guo M et al. (2004) Multiple apoptotic caspase cascades are required in nonapoptotic roles for Drosophila spermatid individualization. PLoS Biol 2: E15.

Daish TJ, Mills K, Kumar S (2004) Drosophila caspase DRONC is required for specific developmental cell death pathways and stress-induced apoptosis. Dev Cell 7: 909–915.

Chew SK, Akdemir F, Chen P, Lu WJ, Mills K, Daish T et al. (2004) The apical caspase dronc governs programmed and unprogrammed cell death in Drosophila. Dev Cell 7: 897–907.

Xu D, Li Y, Arcaro M, Lackey M, Bergmann A (2005) The CARD-carrying caspase Dronc is essential for most, but not all, developmental cell death in Drosophila. Development 132: 2125–2134.

Waldhuber M, Emoto K, Petritsch C (2005) The Drosophila caspase DRONC is required for metamorphosis and cell death in response to irradiation and developmental signals. Mech Dev 122: 914–927.

Kondo S, Senoo-Matsuda N, Hiromi Y, Miura M (2006) DRONC coordinates cell death and compensatory proliferation. Mol Cell Biol 26: 7258–7268.

Mills K, Daish T, Kumar S (2005) The function of the Drosophila caspase DRONC in cell death and development. Cell Cycle 4: 744–746.

Kumar S (2004) Migrate, differentiate, proliferate, or die: pleiotropic functions of an apical ‘apoptotic caspase’. Sci STKE 2004: pe49.

Meier P, Silke J, Leevers SJ, Evan GI (2000) The Drosophila caspase DRONC is regulated by DIAP1. EMBO J 19: 598–611.

Quinn LM, Dorstyn L, Mills K, Colussi PA, Chen P, Coombe M et al. (2000) An essential role for the caspase Dronc in developmentally programmed cell death in Drosophila. J Biol Chem 275: 40416–40424.

Hawkins CJ, Yoo SJ, Peterson EP, Wang SL, Vernooy SY, Hay BA (2000) The Drosophila caspase Dronc cleaves following glutamate or aspartate and is regulated by Diap1, Hid and Grim. J Biol Chem 275: 27084–27093.

Leulier F, Ribeiro PS, Palmer E, Tenev T, Takahashi K, Robertson D et al. (2006) Systematic in vivo RNAi analysis of putative components of the Drosophila cell death machinery. Cell Death Differ 13: 1663–1674.

Cakouros D, Daish T, Martin D, Baehrecke EH, Kumar S (2002) Ecdysone-induced expression of the caspase DRONC during hormone dependent programmed cell death in Drosophila is regulated by Broad-Complex. J Cell Biol 157: 985–995.

Cakouros D, Daish TJ, Kumar S (2004) Ecdysone receptor directly binds the promoter of the Drosophila caspase dronc regulating its expression in specific tissues. J Cell Biol 165: 631–640.

Cakouros D, Daish TJ, Mills K, Kumar S (2004) An arginine-histone methyl transferase, CARMER, coordinates ecdysone-mediated apoptosis in Drosophila cells. J Biol Chem 279: 18467–18471.

Daish T, Cakouros D, Kumar S (2003) Distinct promoter regions regulate spatial and temporal expression of the Drosophila caspase dronc. Cell Death Differ 10: 1348–1356.

Kumar S, Cakouros D (2004) Transcriptional control of the core cell death machinery. Trends Biochem Sci 29: 193–199.

Dorstyn L, Read S, Cakouros D, Huh JR, Hay BA, Kumar S (2002) The role of cytochrome c in caspase activation in Drosophila cells. J Cell Biol 156: 1089–1098.

Kuranaga E, Kanuka H, Tonoki A, Takemoto K, Tomioka T, Kobayashi M et al. (2006) Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell 126: 583–596.

Muro I, Berry DL, Huh JR, Chen CH, Huang H, Yoo SJ et al. (2006) The Drosophila caspase Ice is important for many apoptotic cell deaths and for spermatid individualization, a nonapoptotic process. Development 133: 3305–3315.

Xu D, Wang Y, Willecke R, Chen Z, Ding T, Bergmann A (2006) The effector caspases drICE and dcp-1 have partially overlapping functions in the apoptotic pathway in Drosophila. Cell Death Differ 13: 1697–1706.

Kilpatrick ZE, Cakouros D, Kumar S (2005) Ecdysone-mediated up-regulation of the effector caspase DRICE is required for hormone-dependent apoptosis in Drosophila cells. J Biol Chem 280: 11981–11986.

Fraser AG, McCarthy NJ, Evan GI (1997) drICE is an essential caspase required for apoptotic activity in Drosophila cells. EMBO J 16: 6192–6199.

Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43–50.

Yokoyama H, Mukae N, Sakahira H, Okawa K, Iwamatsu A, Nagata S (2000) A novel activation mechanism of caspase-activated DNase from Drosophila melanogaster. J Biol Chem 275: 12978–12986.

McCall K, Steller H (1998) Requirement for DCP-1 caspase during Drosophila oogenesis. Science 279: 230–234.

Laundrie B, Peterson JS, Baum JS, Chang JC, Fileppo D, Thompson SR et al. (2003) Germline cell death is inhibited by P-element insertions disrupting the dcp-1/pita nested gene pair in Drosophila. Genetics 165: 1881–1888.

Lee CY, Clough EA, Yellon P, Teslovich TM, Stephan DA, Baehrecke EH (2003) Genome-wide analyses of steroid- and radiation-triggered programmed cell death in Drosophila. Curr, Biol 13: 350–357.

Wang SL, Hawkins CJ, Yoo SJ, Muller HA, Hay BA (1999) The Drosophila caspase inhibitor DIAP1 is essential for cell survival and is negatively regulated by HID. Cell 98: 453–463.

Goyal L, McCall K, Agapite J, Hartwieg E, Steller H (2000) Induction of apoptosis by Drosophila reaper, hid and grim through inhibition of IAP function. EMBO J 19: 589–597.

Colussi PA, Quinn LM, Huang DCS, Coombe M, Read SH, Richardson H et al. (2000) Debcl, a pro-apoptotic Bcl-2 homologue, is a component of the Drosophila cell death machinery. J Cell Biol 148: 703–714.

Quinn L, Coomb M, Mills K, Daish T, Colussi P, Kumar S et al. (2003) Buffy, a Drosophila Bcl-2 related protein, has anti-apoptotic and cell cycle inhibitory function. EMBO J 22: 3568–3579.

Vaux DL, Silke J (2005) IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6: 287–297.

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997) Cytochrome c and dATP-dependent formation of Apaf1/caspase-9 complex initiates the apoptotic protease cascade. Cell 91: 479–489.

Dorstyn L, Kumar S (2006) A cytochrome c-free fly apoptosome. Cell Death Differ 13: 1049–1051.

Mills K, Daish T, Harvey KF, Pfleger CM, Hariharan IK, Kumar S (2006) The Drosophila melanogaster Apaf-1 homologue ARK is required for most, but not all, programmed cell death. J Cell Biol 172: 809–815.

Srivastava M, Scherr H, Lackey M, Xu D, Chen Z, Lu J et al. (2006) ARK, the Apaf-1 related killer in Drosophila, requires diverse domains for its apoptotic activity. Cell Death Differ (in press).

Akdemir F, Farkas R, Chen P, Juhasz G, Medved’ova L, Sass M et al. (2006) Autophagy occurs upstream or parallel to the apoptosome during histolytic cell death. Development 133: 1457–1465.

Varkey J, Chen P, Jemmerson R, Abrams JM (1999) Altered cytochrome c display precedes apoptotic cell death in Drosophila. J Cell Biol 144: 701–710.

Zimmermann KC, Ricci JE, Droin NM, Green DR (2002) The role of ARK in stress-induced apoptosis in Drosophila cells. J Cell Biol 156: 1077–1087.

Dorstyn L, Mills K, Lazebnik Y, Kumar S (2004) The two cytochrome c species, DC3 and DC4, are not required for caspase activation and apoptosis in Drosophila cells. J Cell Biol 167: 405–410.

Means JC, Muro I, Clem RJ (2006) Lack of involvement of mitochondrial factors in caspase activation in a Drosophila cell-free system. Cell Death Differ 13: 1222–1234.

Yu X, Wang L, Acehan D, Wang X, Akey CW (2006) Three-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1 related killer. J Mol Biol 355: 577–589.

Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW (2002) Three-dimensional structure of the apoptosome. Implications for assembly, procaspase-9 binding, and activation. Mol Cell 9: 423–432.

Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS et al. (1998) Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 94: 339–352.

Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H et al. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325–337.

Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368–372.

Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727–737.

Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R et al. (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739–750.

Honarpour N, Du C, Richardson JA, Hammer RE, Wang X, Herz J (2000) Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 218: 248–258.

Okamoto H, Shiraishi H, Yoshida H (2006) Histological analyses of normally grown, fertile Apaf1-deficient mice. Cell Death Differ 13: 668–671.

Marsden VS, O’Connor L, O’Reilly LA, Silke J, Metcalf D, Ekert PG et al. (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634–637.

Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A (2004) Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 165: 775–780.

Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, Hawkins CJ et al. (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165: 835–842.

Baliga C, Kumar S (2003) The Apaf-1/cytochrome c apoptosome: an essential initiator of caspase activation or just a sideshow? Cell Death Differ 10: 15–17.

Hao Z, Duncan GS, Chang CC, Elia A, Fang M, Wakeham A et al. (2005) Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement for cytochrome c and Apaf-1 in apoptosis. Cell 121: 579–591.

Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel Mort1/FADD-interacting protease, in Fas/APO1- and TNF receptor-induced cell death. Cell 85: 803–815.

Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, Shevchenko A, Scaffidi C et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827.

Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL et al. (1998) Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267–276.

Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. (2004) Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 173: 2976–2984.

Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395–399.

Yeh WC, de la Pompa JL, McCurrach ME, Shu H-B, Elia AJ, Shahinian A et al. (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954–1958.

Zhang J, Cado D, Kabra NH, Winoto A (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/MORT1. Nature 392: 296–299.

Kabra NH, Kang C, Hsing LC, Zhang J, Winoto A (2001) T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Natl Acad Sci USA 98: 6307–6312.

Zhang Y, Rosenberg S, Wang H, Imtiyaz HZ, Hou YJ, Zhang J (2005) Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J Immunol 175: 3033–3044.

Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P et al. (2001) Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276: 46639–46646.

Milhas D, Cuvillier O, Therville N, Clave P, Thomsen M, Levade T et al. (2005) Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 280: 19836–19842.

Engels IH, Totzke G, Fischer U, Schulze-Osthoff K, Janicke RU (2005) Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner. Mol Cell Biol 25: 2808–2818.

Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S (2006) Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 176: 4520–4524.

Zhu S, Hsu AP, Vacek MM, Zheng L, Schaffer AA, Dale JK et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet 119: 284–294.

Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN et al. (2002) Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99: 4094–4099.

Park WS, Lee JH, Shin MS, Park JY, Kim HS, Lee JH et al. (2002) Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21: 2919–2925.

Butt AJ, Harvey NL, Parasivam G, Kumar S (1998) Dimerization and autoprocessing of the Nedd2(caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem 273: 6763–6768.

Baliga BC, Read SH, Kumar S (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ 11: 1234–1241.

Shearwin-Whyatt LM, Harvey NL, Kumar S (2000) Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD. Cell Death Diff 7: 155–165.

Read SH, Baliga BB, Ekert P, Vaux DL, Kumar S (2002) A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 159: 739–745.

Tinel A, Tschopp J (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304: 843–846.

O’Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL et al. (2002) Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is mediated by Apaf-1 and caspase-9. Cell Death Diff 9: 832–841.

Colussi PA, Harvey NL, Kumar S (1998) Prodomain-dependent nuclear localization of the caspase-2(Nedd2) precursor. J Biol Chem 273: 24535–24542.

Mancini M, Machamer CE, Roy S, Nicholson DW, Thornberry NA, Casciola-Rosen LA et al. (2000) Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 149: 603–612.

Baliga BC, Colussi PA, Read SH, Dias MM, Jans DA, Kumar S (2003) Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. J Biol Chem 278: 4899–4905.

Zhivotovsky B, Orrenius S (2005) Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun 331: 859–867.

Wagner KW, Engels IH, Deveraux QL (2004) Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway. J Biol Chem 279: 35047–35052.

Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K (2005) Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24: 3532–3542.

Tu S, McStay GP, Boucher LM, Mak T, Beere HM, Green DR (2006) In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 8: 72–77.

Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD (2006) Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell 17: 2150–2157.

Nutt LK, Margolis SS, Jensen M, Herman CE, Dunphy WG, Rathmell JC et al. (2005) Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 123: 89–103.

Lavrik IN, Golks A, Baumann S, Krammer PH (2006) Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood 108: 559–565.

Harvey NL, Butt A, Kumar S (1997) Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis. J Biol Chem 272: 13134–13139.

Kumar S (1995) Inhibition of apoptosis by antisense Nedd2 expression. FEBS Lett 368: 69–72.

Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277: 13430–13437.

Troy CM, Shelanski ML (2003) Caspase-2 redux. Cell Death Differ 10: 101–107.

Paroni G, Henderson C, Schneider C, Brancolini C (2002) Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J Biol Chem 277: 15147–15161.

Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S (1998) Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 273: 26566–26570.

Lassus P, Opitz-Araya X, Lazebnik Y (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352–1354.

Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277: 29803–29809.

Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A et al. (1998) Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12: 1304–1314.

Milleron RS, Bratton SB (2006) Heat shock induces apoptosis independently of any known initiator caspase-activating complex. J Biol Chem 281: 16991–17000.

Troy CM, Rabacchi SA, Hohl JB, Angelastro JM, Greene LA, Shelanski ML (2001) Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 21: 5007–5016.

Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99–104.

Lakhani SA, Masud A, Kuida K, Porter Jr GA, Booth CJ, Mehal WZ et al. (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847–851.

Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272: 17907–17911.

Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD et al. (1996) Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93: 8395–8400.

Zheng TS, Hunot S, Kuida K, Flavell RA (1999) Caspase knockouts: matters of life and death. Cell Death Differ 6: 1043–1053.

Loegering DA, Ruchaud S, Earnshaw WC, Kaufmann SH (2006) Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis. Cell Death Differ 13: 346–347.

Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517–521.

Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195.

Thome M, Tschopp J (2001) Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 1: 50–58.

Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181–190.

Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124: 601–613.

Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A et al. (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633–642.

Vaux DL, Silke J (2003) Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 304: 499–504.

Okada H, Suh WK, Jin J, Woo M, Du C, Elia A et al. (2002) Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22: 3509–3517.

Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 24: 9848–9862.

Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB (2001) Characterization of XIAP-deficient mice. Mol Cell Biol 21: 3604–3608.

Beauparlant P, Shore GC (2003) Therapeutic activation of caspases in cancer: a question of selectivity. Curr Opin Drug Discov Devel 6: 179–187.

Schimmer AD, Dalili S, Batey RA, Riedl SJ (2006) Targeting XIAP for the treatment of malignancy. Cell Death Differ 13: 179–188.